empty
 
 

2015.01.1205:02:22UTC+00Roche to buy majority stake in Foundation for up to $1.18 billion

Roche Holding will acquire a majority stake in molecular and genomic analysis firm Foundation Medicine Inc for up to $1.18 billion, it said on Monday, in a move to bolster the Swiss drugmaker's personalized cancer treatments.

Roche said it is looking for the deal to help to develop combination therapies and more accurately identify cancer patients.

 The drug-maker said it will tender for about 15.6 million Foundation shares at $50 a share, worth up to about $780 million, at a premium of 109 percent to their Friday closing price. Roche will also invest $250 million in Foundation by acquiring 5 million newly issued shares at $50 per share.

The transactions will result in Roche owning between 52.4 percent and 56.3 percent of Foundation. Roche will obtain minority representation on the board of Foundation.

The collaboration will focus on developing genomic profile tests for cancer immunotherapies and for continuous blood-based monitoring.  

  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST
  • Chancy Deposit
    Deposit your account with $3,000 and get $1000 more!
    In April we raffle $1000 within the Chancy Deposit campaign!
    Get a chance to win by depositing $3,000 to a trading account. Having fulfilled this condition, you become a campaign participant.
    JOIN CONTEST
  • Trade Wise, Win Device
    Top up your account with at least $500, sign up for the contest, and get a chance to win mobile devices.
    JOIN CONTEST
  • 100% Bonus
    Your unique opportunity to get a 100% bonus on your deposit
    GET BONUS
  • 55% Bonus
    Apply for a 55% bonus on your every deposit
    GET BONUS
  • 30% Bonus
    Receive a 30% bonus every time you top up your account
    GET BONUS


Can't speak right now?
Ask your question in the chat.
Widget callback